Johan Ljungberg1, Mikael Janiec2,3, Ingvar A Bergdahl4, Anders Holmgren1, Johan Hultdin5, Bengt Johansson1, Ulf Näslund1, Agneta Siegbahn6, Tove Fall3, Stefan Söderberg1. 1. Departments of Public Health and Clinical Medicine (J.L., A.H., B.J., U.N., S.S.). 2. Umeå University, Sweden. Departments of Cardiothoracic Surgery and Anaesthesia (M.J.). 3. Medical Sciences, Molecular Epidemiology and Science for Life Laboratory (M.J., T.F.). 4. Biobank Research (I.A.B.). 5. Medical Biosciences (J.H.). 6. Medical Sciences, Clinical Chemistry and Science for Life Laboratory (A.S.), Uppsala University, Sweden.
Abstract
BACKGROUND: Aortic valve stenosis (AS) is the most common indication for cardiac valve surgery; untreated AS is linked to high mortality. The etiological background of AS is unknown. Previous human studies were typically based on case-control studies. Biomarkers identified in prospective studies could lead to novel mechanistic insights. METHODS: Within a large population survey with blood samples obtained at baseline, 334 patients were identified who later underwent surgery for AS (median age [interquartile range], 59.9 [10.4] years at survey and 68.3 [12.7] at surgery; 48% female). For each case, 2 matched referents were allocated. Plasma was analyzed with the multiplex proximity extension assay for screening of 92 cardiovascular candidate proteins. Conditional logistic regression models were used to assess associations between each protein and AS, with correction for multiple testing. A separate set of 106 additional cases with 212 matched referents was used in a validation study. RESULTS: Six proteins (growth differentiation factor 15, galectin-4, von Willebrand factor, interleukin 17 receptor A, transferrin receptor protein 1, and proprotein convertase subtilisin/kexin type 9) were associated with case status in the discovery cohort; odds ratios ranged from 1.25 to 1.37 per SD increase in the protein signal. Adjusting the multivariable models for classical cardiovascular risk factors at baseline yielded similar results. Subanalyses of case-referent triplets (n=133) who showed no visible coronary artery disease at the time of surgery in the index person supported associations between AS and growth differentiation factor 15 (odds ratio, 1.40; 95% confidence interval, 1.10-1.78) and galectin-4 (odds ratio, 1.27; 95% confidence interval, 1.02-1.59), but these associations were attenuated after excluding individuals who donated blood samples within 5 years before surgery. In triplets (n=201), which included index individuals with concurrent coronary artery disease at the time of surgery, all 6 proteins were robustly associated with case status in all sensitivity analyses. In the validation study, the association of all but 1 (interleukin 17 receptor A) of these proteins were replicated in patients with AS with concurrent coronary artery disease but not in patients with AS without coronary artery disease. CONCLUSIONS: We provide evidence that 5 proteins were altered years before AS surgery and that the associations seem to be driven by concurrent atherosclerotic disease.
BACKGROUND:Aortic valve stenosis (AS) is the most common indication for cardiac valve surgery; untreated AS is linked to high mortality. The etiological background of AS is unknown. Previous human studies were typically based on case-control studies. Biomarkers identified in prospective studies could lead to novel mechanistic insights. METHODS: Within a large population survey with blood samples obtained at baseline, 334 patients were identified who later underwent surgery for AS (median age [interquartile range], 59.9 [10.4] years at survey and 68.3 [12.7] at surgery; 48% female). For each case, 2 matched referents were allocated. Plasma was analyzed with the multiplex proximity extension assay for screening of 92 cardiovascular candidate proteins. Conditional logistic regression models were used to assess associations between each protein and AS, with correction for multiple testing. A separate set of 106 additional cases with 212 matched referents was used in a validation study. RESULTS: Six proteins (growth differentiation factor 15, galectin-4, von Willebrand factor, interleukin 17 receptor A, transferrin receptor protein 1, and proprotein convertase subtilisin/kexin type 9) were associated with case status in the discovery cohort; odds ratios ranged from 1.25 to 1.37 per SD increase in the protein signal. Adjusting the multivariable models for classical cardiovascular risk factors at baseline yielded similar results. Subanalyses of case-referent triplets (n=133) who showed no visible coronary artery disease at the time of surgery in the index person supported associations between AS and growth differentiation factor 15 (odds ratio, 1.40; 95% confidence interval, 1.10-1.78) and galectin-4 (odds ratio, 1.27; 95% confidence interval, 1.02-1.59), but these associations were attenuated after excluding individuals who donated blood samples within 5 years before surgery. In triplets (n=201), which included index individuals with concurrent coronary artery disease at the time of surgery, all 6 proteins were robustly associated with case status in all sensitivity analyses. In the validation study, the association of all but 1 (interleukin 17 receptor A) of these proteins were replicated in patients with AS with concurrent coronary artery disease but not in patients with AS without coronary artery disease. CONCLUSIONS: We provide evidence that 5 proteins were altered years before AS surgery and that the associations seem to be driven by concurrent atherosclerotic disease.
Authors: Christoph Nowak; Axel C Carlsson; Carl Johan Östgren; Fredrik H Nyström; Moudud Alam; Tobias Feldreich; Johan Sundström; Juan-Jesus Carrero; Jerzy Leppert; Pär Hedberg; Egil Henriksen; Antonio C Cordeiro; Vilmantas Giedraitis; Lars Lind; Erik Ingelsson; Tove Fall; Johan Ärnlöv Journal: Diabetologia Date: 2018-05-24 Impact factor: 10.122
Authors: Eva Warensjö Lemming; Liisa Byberg; Karl Stattin; Shafqat Ahmad; Lars Lind; Sölve Elmståhl; Susanna C Larsson; Alicja Wolk; Karl Michaëlsson Journal: J Am Heart Assoc Date: 2019-06-01 Impact factor: 5.501
Authors: Dan Haberman; Gil Chernin; Valery Meledin; Meital Zikry; Mony Shuvy; Gera Gandelman; Sorel Goland; Jacob George; Sara Shimoni Journal: PLoS One Date: 2020-03-11 Impact factor: 3.240
Authors: John Molvin; Amra Jujić; Olle Melander; Manan Pareek; Lennart Råstam; Ulf Lindblad; Bledar Daka; Margrét Leósdóttir; Peter M Nilsson; Michael H Olsen; Martin Magnusson Journal: ESC Heart Fail Date: 2020-10-13
Authors: Anders Holmgren; Johan Ljungberg; Johan Hultdin; Bengt Johansson; Ingvar A Bergdahl; Ulf Näslund; Stefan Söderberg Journal: Open Heart Date: 2020-10